Atypical patterns of response to immune checkpoint inhibitors: interpreting pseudoprogression and hyperprogression in decision making for patients' treatment

被引：32
作者：
Onesti, Concetta Elisa [1 ,2 ,3 ]
Freres, Pierre [2 ]
Jerusalem, Guy [2 ,3 ]
机构：
[1] Univ Liege, GIGA Res Inst, Lab Human Genet, Liege, Belgium
[2] CHU Liege, Univ Hosp, Dept Med Oncol, Ave Hop 1, B-4000 Liege, Belgium
[3] Univ Liege, GIGA Res Inst, Lab Med Oncol, Liege, Belgium
来源：
JOURNAL OF THORACIC DISEASE | 2019年 / 11卷 / 01期
关键词：
IPILIMUMAB; NIVOLUMAB; DOCETAXEL;
D O I：
10.21037/jtd.2018.12.47
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：35 / 38
页数：4
相关论文
共 50 条
  • [41] Effect of antibiotic treatment on immune checkpoint inhibitors efficacy in patients with advanced non-small cell lung cancer
    Sen, Guelin Alkan
    Oztas, Nihan Senturk
    Degerli, Ezgi
    Can, Gunay
    Turna, Hande
    Ozguroglu, Mustafa
    LUNG CANCER, 2023, 184
  • [42] Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors
    Yosuke Ando
    Takahiro Hayashi
    Reiko Sugimoto
    Seira Nishibe
    Kaori Ito
    Kenji Kawada
    Yoshiaki Ikeda
    Shigeki Yamada
    Kazuyoshi Imaizumi
    Investigational New Drugs, 2020, 38 : 1200 - 1206
  • [43] Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
    Cass, S. H.
    Tobin, J. W. D.
    Seo, Y. D.
    Gener-Ricos, G.
    Keung, E. Z.
    Burton, E. M.
    Davies, M. A.
    Mcquade, J. L.
    Lazar, A. J.
    Mason, R.
    Millward, M.
    Sandhu, S.
    Khoo, C.
    Warburton, L.
    Guerra, V.
    Haydon, A.
    Dearden, H.
    Menzies, A. M.
    Carlino, M. S.
    Smith, J. L.
    Mollee, P.
    Burgess, M.
    Mapp, S.
    Keane, C.
    Atkinson, V.
    Parikh, S. A.
    Markovic, S. N.
    Ding, W.
    Call, T. G.
    Hampel, P. J.
    Long, G., V
    Wargo, J. A.
    Ferrajoli, A.
    ANNALS OF ONCOLOGY, 2023, 34 (09) : 796 - 805
  • [44] Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: An integrative review
    Santos Freitas, Julia de Almeida
    Bendicho, Maria Teresita
    Santos Jr, Anibal de Freitas
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023,
  • [45] Neoadjuvant treatment with immune checkpoint inhibitors in patients with melanoma: A real-life retrospective study
    Tomsitz, Dirk
    Zimmermann, Petra
    Kunz, Wolfgang G.
    Neumann, Jens
    Siegmund, Birte J.
    Weiss, Bernhard G.
    Kauke, Teresa
    Sienel, Wulf
    French, Lars E.
    Klauschen, Frederick
    Heinzerling, Lucie
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2025,
  • [46] Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma
    Wind, Thijs T.
    Gacesa, Ranko
    Vich Vila, Arnau
    de Haan, Jacco J.
    Jalving, Mathilde
    Weersma, Rinse K.
    Hospers, Geke A. P.
    MELANOMA RESEARCH, 2020, 30 (03) : 235 - 246
  • [47] The genomic characteristics of different progression patterns in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Li, Jingwen
    Xiang, Chan
    Wang, Yue
    Zhou, Yan
    Cao, Shuhui
    Ling, Xuxinyi
    Ye, Junyi
    Zheng, Jingjing
    Shao, Lin
    Zhong, Hua
    Han, Yuchen
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (09)
  • [48] Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer
    Wang, Zhenghang
    Liu, Chang
    Bai, Yuezong
    Zhao, Xiaochen
    Cui, Longgang
    Peng, Zhi
    Zhang, Xiaotian
    Wang, Xicheng
    Zhao, Zhengyi
    Li, Jian
    Shen, Lin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Saleh, Khalil
    Daste, Amaury
    Martin, Nicolas
    Pons-Tostivint, Elvire
    Auperin, Anne
    Herrera-Gomez, Ruth Gabriela
    Baste-Rotllan, Neus
    Bidault, Francois
    Guigay, Joel
    Le Tourneau, Christophe
    Saada-Bouzid, Esma
    Even, Caroline
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 123 - 129
  • [50] Patients deriving long-term benefit from immune checkpoint inhibitors demonstrate conserved patterns of site-specific mutations
    Principe, Daniel R.
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345